ID: ALA2113403

Max Phase: Preclinical

Molecular Formula: C15H19N7O4

Molecular Weight: 361.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CCN)nc32)[C@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C15H19N7O4/c1-2-18-14(25)11-9(23)10(24)15(26-11)22-6-19-8-12(17)20-7(4-3-5-16)21-13(8)22/h6,9-11,15,23-24H,2,5,16H2,1H3,(H,18,25)(H2,17,20,21)/t9-,10+,11-,15+/m0/s1

Standard InChI Key:  HVKXOYTYMQXKGY-BQVMBELUSA-N

Associated Targets(Human)

ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adora1 Adenosine A1 receptor (6163 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adora2b Adenosine A2 receptor (1828 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adora2b Adenosine receptors; A1 & A2 (886 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 361.36Molecular Weight (Monoisotopic): 361.1499AlogP: -2.53#Rotatable Bonds: 3
Polar Surface Area: 174.43Molecular Species: NEUTRALHBA: 10HBD: 5
#RO5 Violations: 0HBA (Lipinski): 11HBD (Lipinski): 7#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.39CX Basic pKa: 8.30CX LogP: -1.77CX LogD: -2.72
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.37Np Likeness Score: 0.50

References

1. Cristalli G, Volpini R, Vittori S, Camaioni E, Monopoli A, Conti A, Dionisotti S, Zocchi C, Ongini E..  (1994)  2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation.,  37  (11): [PMID:8201607] [10.1021/jm00037a024]

Source